avidity biosciences

avidity biosciences

NASDAQ:RNA
Avidity Biosciences

Chart

Detailed Quote

Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to treat a rare monogenic muscle disease.

Featured Articles and Interviews
A floating DNA double helix above a hand with a blue background.

Top 4 NASDAQ Genetics Stocks (Updated January 2026)

Hand holding glowing DNA strands with molecular structures.

How to Invest in Gene Stocks and ETFs

A floating DNA double helix above a hand with a blue background.

Top 5 NASDAQ Genetics Stocks (Updated January 2025)

Press Releases

Atrium Therapeutics Announces FDA Clearance of Investigational New Drug Application for ATR 1072 for Treatment of PRKAG2 Syndrome

Atrium Therapeutics Reports First Quarter 2026 Financial Results

Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635

The Conversation (0)